957 related articles for article (PubMed ID: 16197336)
21. Reciprocal activating interaction between natural killer cells and dendritic cells.
Gerosa F; Baldani-Guerra B; Nisii C; Marchesini V; Carra G; Trinchieri G
J Exp Med; 2002 Feb; 195(3):327-33. PubMed ID: 11828007
[TBL] [Abstract][Full Text] [Related]
22. Natural killer cells: the secret weapon in dendritic cell vaccination strategies.
Van Elssen CH; Oth T; Germeraad WT; Bos GM; Vanderlocht J
Clin Cancer Res; 2014 Mar; 20(5):1095-103. PubMed ID: 24590885
[TBL] [Abstract][Full Text] [Related]
23. Helper roles of NK and CD8+ T cells in the induction of tumor immunity. Polarized dendritic cells as cancer vaccines.
Kalinski P; Nakamura Y; Watchmaker P; Giermasz A; Muthuswamy R; Mailliard RB
Immunol Res; 2006; 36(1-3):137-46. PubMed ID: 17337774
[TBL] [Abstract][Full Text] [Related]
24. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions.
Gerosa F; Gobbi A; Zorzi P; Burg S; Briere F; Carra G; Trinchieri G
J Immunol; 2005 Jan; 174(2):727-34. PubMed ID: 15634892
[TBL] [Abstract][Full Text] [Related]
25. Reciprocal activating interaction between 6-sulfo LacNAc+ dendritic cells and NK cells.
Wehner R; Löbel B; Bornhäuser M; Schäkel K; Cartellieri M; Bachmann M; Rieber EP; Schmitz M
Int J Cancer; 2009 Jan; 124(2):358-66. PubMed ID: 18942710
[TBL] [Abstract][Full Text] [Related]
26. Dendritic cell interactions with NK cells from different tissues.
Ferlazzo G; Münz C
J Clin Immunol; 2009 May; 29(3):265-73. PubMed ID: 19280325
[TBL] [Abstract][Full Text] [Related]
27. HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8
Yu Z; Liu W; He Y; Sun M; Yu J; Jiao X; Han Q; Tang H; Zhang B; Xian Y; Qi J; Gong J; Xin W; Shi G; Shan F; Zhang R; Li J; Wei M
J Hematol Oncol; 2021 Apr; 14(1):71. PubMed ID: 33910591
[TBL] [Abstract][Full Text] [Related]
28. DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction.
Adam C; King S; Allgeier T; Braumüller H; Lüking C; Mysliwietz J; Kriegeskorte A; Busch DH; Röcken M; Mocikat R
Blood; 2005 Jul; 106(1):338-44. PubMed ID: 15769894
[TBL] [Abstract][Full Text] [Related]
29. Natural killer cells and dendritic cells: rendezvous in abused tissues.
Moretta A
Nat Rev Immunol; 2002 Dec; 2(12):957-64. PubMed ID: 12461568
[TBL] [Abstract][Full Text] [Related]
30. The Natural Killer-Dendritic Cell Immune Axis in Anti-Cancer Immunity and Immunotherapy.
Peterson EE; Barry KC
Front Immunol; 2020; 11():621254. PubMed ID: 33613552
[TBL] [Abstract][Full Text] [Related]
31. Potency of Both Human Th1 and NK Helper Cell Activation is Determined by IL-12p70-Producing PAMP-Matured DCs.
Oth T; Van Elssen CH; Schnijderberg MC; Senden-Gijsbers BL; Germeraad WT; Bos GM; Vanderlocht J
J Interferon Cytokine Res; 2015 Sep; 35(9):748-58. PubMed ID: 26134473
[TBL] [Abstract][Full Text] [Related]
32. Dendritic cell-induced activation of adaptive and innate antitumor immunity.
van den Broeke LT; Daschbach E; Thomas EK; Andringa G; Berzofsky JA
J Immunol; 2003 Dec; 171(11):5842-52. PubMed ID: 14634094
[TBL] [Abstract][Full Text] [Related]
33. CD40-independent natural killer-cell help promotes dendritic cell vaccine-induced T-cell immunity against endogenous B-cell lymphoma.
Hömberg N; Adam C; Riedel T; Brenner C; Flatley A; Röcken M; Mocikat R
Int J Cancer; 2014 Dec; 135(12):2825-33. PubMed ID: 24771135
[TBL] [Abstract][Full Text] [Related]
34. Effector and regulatory events during natural killer-dendritic cell interactions.
Moretta L; Ferlazzo G; Bottino C; Vitale M; Pende D; Mingari MC; Moretta A
Immunol Rev; 2006 Dec; 214():219-28. PubMed ID: 17100887
[TBL] [Abstract][Full Text] [Related]
35. NK/DC crosstalk in anti-viral response.
Marcenaro E; Carlomagno S; Pesce S; Moretta A; Sivori S
Adv Exp Med Biol; 2012; 946():295-308. PubMed ID: 21948375
[TBL] [Abstract][Full Text] [Related]
36. Dendritic cells in innate immune responses against HIV.
Servet C; Zitvogel L; Hosmalin A
Curr Mol Med; 2002 Dec; 2(8):739-56. PubMed ID: 12462394
[TBL] [Abstract][Full Text] [Related]
37. Natural-killer cells and dendritic cells: "l'union fait la force".
Walzer T; Dalod M; Robbins SH; Zitvogel L; Vivier E
Blood; 2005 Oct; 106(7):2252-8. PubMed ID: 15933055
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of antitumor effect using dendritic cells activated with natural killer cells in the presence of Toll-like receptor agonist.
Pham TN; Hong CY; Min JJ; Rhee JH; Nguyen TA; Park BC; Yang DH; Park YK; Kim HR; Chung IJ; Kim HJ; Lee JJ
Exp Mol Med; 2010 Jun; 42(6):407-19. PubMed ID: 20386085
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization of Enterococcus faecalis isolates from urinary tract infection and interaction between Enterococcus faecalis encountered Dendritic and Natural Killer cells.
Kathirvel S; Mani M; Gopala Krishnan GK; Sethumadhavan A; Vijayalakshmi T; Ponnan SM; Hanna LE; Mathaiyan M
Microb Pathog; 2020 Mar; 140():103944. PubMed ID: 31877329
[TBL] [Abstract][Full Text] [Related]
40. Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection.
Jinushi M; Takehara T; Tatsumi T; Kanto T; Miyagi T; Suzuki T; Kanazawa Y; Hiramatsu N; Hayashi N
J Immunol; 2004 Nov; 173(10):6072-81. PubMed ID: 15528343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
